Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples-Reference-Cited by-同舟云学术

Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples

Published:2017-11 Issue:6 Volume:18 Page:682-691.e5
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Casadevall David^ORCID,Clavé Sergi,Taus Álvaro,Hardy-Werbin Max,Rocha Pedro,Lorenzo Marta,Menéndez Silvia,Salido Marta,Albanell Joan,Pijuan Lara,Arriola Edurne

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference46 articles.

1. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion;Schreiber;Science,2011

2. Hallmarks of cancer: the next generation;Roizen;Yearb Anesthesiol Pain Manag,2012

3. Improved survival with ipilimumab in patients with metastatic melanoma;Sosman;N Engl J Med,2010

4. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N Engl J Med,2012

5. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma;Postow;N Engl J Med,2015

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fit-for-Purpose Ki-67 Immunohistochemistry Assays for Breast Cancer;Laboratory Investigation;2024-07

2. Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity Foundation;Archives of Pathology & Laboratory Medicine;2024-04-16

3. Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC;Journal for ImmunoTherapy of Cancer;2024-04

4. Soluble Immune Checkpoint Molecules as Predictors of Efficacy in Immuno-Oncology Combination Therapy in Advanced Renal Cell Carcinoma;Current Oncology;2024-03-22

5. Immune characteristics of dedifferentiated retroperitoneal liposarcomas and the reliability of regional samples in evaluating their tumor immune microenvironments;World Journal of Surgical Oncology;2024-01-23